Cancer Immunotherapy Market Top Players and Growth Strategies

 Rosy wills
  13th-Jun-2019
 74

According to the new market research report Cancer Immunotherapy Market is expected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0% from 2016 to 2021. The global cancer immunotherapy market is consolidated in nature, marked with the presence of a few large players. The prominent players in this market are Amgen (U.S.), AstraZeneca (U.K.), F. Hoffmann-La Roche Ltd(Switzerland), Bayer AG (Germany), Bristol-Myers Squibb (U.S.), Eli Lilly and Company (U.S.), Janssen Global Services, LLC (Belgium), Merck (U.S.), Novartis (Switzerland), and Pfizer (U.S.).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=197577894

Amgen was the largest player in the global cancer immunotherapy market in 2015. The company has a strong presence in the U.S., Europe, Asia-Pacific, the Middle East, and Africa. In order to sustain its foothold and further increase its share in the market, the company pursues the strategy of new product launches, which significantly impacts the company’s customer base.

In 2015, F. Hoffmann-La Roche AG accounted for the second-largest share in the cancer immunotherapy market. The company focuses on developing innovative products to provide efficient solutions to its customers.

Bristol-Myers Squibb (BMS) held the third position in the cancer immunotherapy market in 2015. The company has a first-mover advantage as two of its drugs (Opdivo and Yervoy) have already been approved and commercialized. These products recently received an approval of oncolytic virus Imlygic and cancer vaccine Empliciti from the U.S. FDA.

Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197577894

The key strategies followed by most companies in the cancer immunotherapy market are new products launches and approvals; expansions; acquisitions; and partnerships, agreements, and collaborations. The strategy of new products launches and approvals accounted for the largest share of the overall growth strategies mapped from 2013 to 2016. Companies seek new and advanced product approvals to strengthen their product portfolios and cater to the unmet needs of their customers. Some of the leading players that adopted this strategy include Amgen (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb (U.S.), and Merck (U.S.).

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

newsletter@marketsandmarkets.com

Domain: Medical
Category: Biotech/Pharma
Posted By: Rosy wills and Contact Rosy wills

Recent Press Releases

Kokopelli Inn With Offers Special Ov...

Estes Park, CO (Sept 21, 2019): Kokopelli Inn will offer the visitors with the most exceptional Mountain biking trails in Estes Park. The main aim of backpacking guides is to help

21 September, 2019

Anti-Counterfeiting Packaging Market...

The global anti-counterfeit packaging market size is forecasted to value over USD 211 billion by 2026 end and grow at a CAGR of 7.2% during the forecast period, 2019 to 2026. Wit

21 September, 2019

ROOT Periodontal & Implant Center Ex...

Frisco, TX - September 21, 2019 - Frisco residents are being offered the best in dental services with the opening of a new clinic by ROOT Periodontal & Implant Center. ROOT P

21 September, 2019